Clinical Trials Logo
  1. Home
  2. Thyrotoxicosis
  3. NCT02886949
  4. Details
NCT02886949 Clinical Trial

The Association Between Autoimmune or Inflammation and Thyroid Disease

THYROTOXICOSIS Clinical Trial

Official title:
The Relationship of Vascular Cell Adhesion Molecule 1, C-reactive Protein, Brain-derived Neurotrophic Factor, Orexin and Depressive Symptoms in the Subjects With Thyroid Disease

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT02886949
Other study ID # CE11307
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 2011
Est. completion date December 2024

Study information
Verified date January 2020
Source Taichung Veterans General Hospital
Contact I-Te Lee, MD
Email itlee@vghtc.gov.tw
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study aims to evaluate the effects of thyroid functions on energy homeostasis and inflammation.

Description:

The subjects were enrolled for evaluation of thyroid functions. The associations between thyroid function and energy homeostasis and inflammation will be assessed.

Recruitment information / eligibility
Status Recruiting
Enrollment 500
Est. completion date December 2024
Est. primary completion date December 2020
Accepts healthy volunteers No
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria:

- Subjects visits outpatient department due to a suspicion of thyroid disease

Exclusion Criteria:

- Psychological disorders, severe inflammatory or infection diseases.

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Taiwan Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital Taichang

Sponsors (1)
Lead Sponsor Collaborator
Taichung Veterans General Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome
Type Measure Description Time frame Safety issue
Primary brain-derived neurotrophic factor BDNF 3 months
Secondary vascular cell adhesion molecule 1 (VCAM-1) Inflammation 3 months
Secondary C-reactive protein (CRP) Inflammation 3 months
Secondary Orexin Psychological assessment 3 month
Secondary Zung Self-Rating Depression Scale (Zung SDS) Depressive symptom 3 month
Secondary Body composition fat component 3 month
Secondary ankle brachial index (ABI) Arterial stiffness 3 months
Secondary pulse wave velocity (PWV) Arterial stiffness 3 months
Secondary mean arterial pressure (MAP) Arterial stiffness 3 months
See also
  Status Clinical Trial Phase
Completed NCT06391515 - Subacute Thyroiditis in the SARS-CoV-2 Era
Completed NCT03009357 - Clinical Application of Pulse Rate-monitoring Activity Trackers in Thyrotoxicosis
Not yet recruiting NCT06264544 - Trial to Evaluate the Efficacy of a Zinc, Selenium, and L-Tyrosine Supplement in the Prevention of Thyrotoxicosis in Subjects With r25191G/A SEPP1 Polymorphism N/A
Completed NCT01227499 - Differential Diagnosis of STA-PSV in Thyrotoxicosis N/A
Completed NCT02767245 - Thiamine Supplement in Patients With Severe Hyperthyroidism N/A
Recruiting NCT04806269 - Biosignals by Wearables in Thyroid Dysfunction
Completed NCT04485975 - Therapeutic Plasma Exchange in Thyrotoxicosis